“the actual submission is likely to be early 2024, after the...

“the actual submission is likely to be early 2024, after the adult trial commences.but if the FDA suggest that an AA submission would be a viable option, then that will bring forward potential approval by a fair bit as the AA review itself is unlikely to take very long with the manufacturing inspection already given the green tick. We will know shortly as @ddwn suggests, but clearly this possibility is not factored into the current share price and presents an opportunity for those who think it could come to fruition.” —> This was @stockrock ‘s reply to @07Gerard on 10 Aug.

If you are interested, I think @stockrock gave some background to the thinking in his reply - you can do an advanced search for his earlier post on the same day.

I wonder if anyone would be asking this process question at the upcoming results CC - seems to me to be highly relevant, @LearningEachDay, @ddwn, @Phaedrus - any thoughts?